» Authors » Heinz Feldmann

Heinz Feldmann

Explore the profile of Heinz Feldmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 475
Citations 21011
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Rao D, Meade-White K, Leventhal S, Mihalakakos E, Carmody A, Feldmann H, et al.
EBioMedicine . 2023 Oct; 97:104839. PMID: 37866114
Background: Crimean-Congo haemorrhagic fever (CCHF) is a serious viral hemorrhagic fever caused by the CCHF virus (CCHFV). Spread by the bites of infected ticks or handling of viremic livestock, human...
22.
Clancy C, Meade-White K, Shaia C, Saturday G, Feldmann H, Rosenke K
Vet Sci . 2023 Sep; 10(9). PMID: 37756057
Coronavirus Infectious Disease 2019 (COVID-19) initiated a global pandemic that thus far has resulted in the death of over 6.5 million people internationally. Understanding the viral tropism during the initial,...
23.
Bhatia B, Tang-Huau T, Feldmann F, Hanley P, Rosenke R, Shaia C, et al.
Sci Adv . 2023 Sep; 9(36):eadj1428. PMID: 37672587
Kyasanur Forest disease virus (KFDV) is an endemic arbovirus in western India mainly transmitted by hard ticks of the genus . KFDV causes Kyasanur Forest disease (KFD), a syndrome including...
24.
Hansen F, Vucak M, Nichols J, Hughes J, Bane S, Camiolo S, et al.
J Gen Virol . 2023 Aug; 104(8). PMID: 37643006
Distinct cytomegaloviruses (CMVs) are widely distributed across their mammalian hosts in a highly host species-restricted pattern. To date, evidence demonstrating this has been limited largely to PCR-based approaches targeting small,...
25.
Tipih T, Meade-White K, Rao D, Bushmaker T, Lewis M, Shaia C, et al.
Antiviral Res . 2023 Aug; 218:105703. PMID: 37611878
Crimean-Congo hemorrhagic fever virus (CCHFV) causes Crimean-Congo hemorrhagic fever (CCHF) in humans with high morbidity and mortality. Currently, there is neither an approved antiviral drug nor a vaccine against CCHFV....
26.
Sprecher A, Cross R, Marzi A, Martins K, Wolfe D, Montgomery J, et al.
J Infect Dis . 2023 Aug; 228(Suppl 7):S474-S478. PMID: 37596837
Although there are now approved treatments and vaccines for Ebola virus disease, the case fatality rate remains unacceptably high even when patients are treated with the newly approved therapeutics. Furthermore,...
27.
Kuroda M, Halfmann P, Thackray L, Diamond M, Feldmann H, Marzi A, et al.
J Infect Dis . 2023 Aug; 228(Suppl 7):S514-S521. PMID: 37562033
Ebola virus (EBOV) is a highly pathogenic virus that encodes 7 multifunctional structural proteins. Multiple host factors have been reported to interact with the EBOV proteins. Here, we found that...
28.
Marzi A, Hanley P, Furuyama W, Haddock E, Martens C, Scott D, et al.
J Infect Dis . 2023 Jul; 228(Suppl 7):S617-S625. PMID: 37477943
Ebola virus (EBOV)-Makona infected more than 30 000 people from 2013 to 2016 in West Africa, among them many health care workers including foreign nationals. Most of the infected foreign...
29.
Bushmaker T, Feldmann F, Lovaglio J, Saturday G, Griffin A, ODonnell K, et al.
J Infect Dis . 2023 Jul; 228(Suppl 7):S721-S729. PMID: 37474155
Vesicular stomatitis virus-Ebola virus (VSV-EBOV) vaccine has been successfully used in ring vaccination approaches during EBOV disease outbreaks demonstrating its general benefit in short-term prophylactic vaccination, but actual proof of...
30.
de Wit E, Williamson B, Feldmann F, Goldin K, Lo M, Okumura A, et al.
Antiviral Res . 2023 Jun; 216:105658. PMID: 37356729
Remdesivir is a nucleotide prodrug with preclinical efficacy against lethal Nipah virus infection in African green monkeys when administered 1 day post inoculation (dpi) (Lo et al., 2019). Here, we...